High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer.

Journal Article (Clinical Trial;Journal Article)

Full Text

Duke Authors

Cited Authors

  • Shpall, EJ; Clarke-Pearson, D; Soper, JT; Berchuck, A; Jones, RB; Bast, RC; Ross, M; Lidor, Y; Vanacek, K; Tyler, T

Published Date

  • September 1990

Published In

Volume / Issue

  • 38 / 3

Start / End Page

  • 386 - 391

PubMed ID

  • 2121627

Pubmed Central ID

  • 2121627

International Standard Serial Number (ISSN)

  • 0090-8258

Digital Object Identifier (DOI)

  • 10.1016/0090-8258(90)90079-z

Language

  • eng

Conference Location

  • United States